COVID-19 Archive — Page 2 of 33
-
March 9, 2023
Study finds RSV may evade vaccines via rapid mutation
A Vanderbilt study concluded that RSV’s ability to mutate rapidly to escape detection by the body’s immune system makes it more challenging to design and develop vaccines that can stop it from spreading. -
February 2, 2023
COVID-19 battle begins in the nose
A high upper airway concentration of the virus that causes COVID-19 was associated with changes in gene expression that could impact disease progression, Vanderbilt researchers discovered. -
January 26, 2023
Study to explore COVID’s impact on essential workers
Vanderbilt researchers are inviting non-health care essential workers to participate in a study to better understand how they continue to be impacted by COVID-19. -
January 19, 2023
Emerging Infections Program lands national award for COVID response
Vanderbilt's Emerging Infections Program (EIP) recently received the Toby Merlin Award for Excellence in Emergency Response, presented by the Centers for Disease Control and Prevention (CDC) and the Agency for Toxic Substances and Disease Registry. -
January 5, 2023
VUMC-led COVID-19 clinical trial platform goes international
The ACTIV-4 Host Tissue clinical trial platform, which is designed to investigate therapies targeting the host tissue response to COVID-19 to mitigate lung injury, is now being expanded internationally. -
January 4, 2023
VUMC strongly recommends COVID-19 bivalent booster vaccination as new COVID-19 variants appear in our region
With the development of new variants of the COVID-19 virus across the U.S. and the world, Vanderbilt University Medical Center recommends getting the bivalent booster vaccination. -
December 16, 2022
Bivalent booster vaccine effective in preventing COVID-19 hospitalization in older adults
The new bivalent mRNA COVID-19 booster vaccines that began being used in September are beneficial in preventing COVID-19-associated hospitalization in persons 65 and over.